Product Program year 2019 Source: CMS Open Payments

Breo

Drug Respiratory

NDC 0173-0859-10

Open in the dashboard

General payments

$269,339

20,930 payments

Research payments

$0

0 payments

Through program year 2019, $269,339 in general payments and $0 in research payments were reported against Breo (Respiratory).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2019 General $269,339 20,930

Breakdown

Who paid General payments · program year 2019
  1. GlaxoSmithKline, LLC. $269,339 20,930 payments
Top recipients General payments · program year 2019
  1. Eisenhower Medical Center Teaching hospital · CA $750 <1% · 1 payment
  2. Rodolfo Trejo Family Medicine · Atlantis, FL $282 <1% · 13 payments
  3. Boris Sagalovich Pulmonary Disease · Brooklyn, NY $209 <1% · 10 payments
  4. Suneesh Nair Pulmonary Disease · Sugar Land, TX $208 <1% · 16 payments
  5. Eduardo Andre Pulmonary Disease · Pembroke Pines, FL $206 <1% · 10 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Family Medicine $72,479 27% · 2,916 practitioners
  2. Pulmonary Disease Internal Medicine $72,425 27% · 2,033 practitioners
  3. Internal Medicine $59,804 23% · 2,154 practitioners
  4. Allergy & Immunology $27,158 10% · 724 practitioners
  5. Critical Care Medicine Internal Medicine $6,628 3% · 197 practitioners

The top 5 of 85 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. Florida $26,066 10% · 765 recipients
  2. Pennsylvania $22,407 8% · 746 recipients
  3. New York $19,399 7% · 657 recipients
  4. Texas $18,983 7% · 607 recipients
  5. California $18,679 7% · 596 recipients

The top 5 of 50 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

20,930 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record